97 related articles for article (PubMed ID: 17544798)
1. Examination of an inducible expression system for limiting iron availability during Chlamydia trachomatis infection.
Dill BD; Raulston JE
Microbes Infect; 2007 Jul; 9(8):947-53. PubMed ID: 17544798
[TBL] [Abstract][Full Text] [Related]
2. Response of Chlamydia trachomatis serovar E to iron restriction in vitro and evidence for iron-regulated chlamydial proteins.
Raulston JE
Infect Immun; 1997 Nov; 65(11):4539-47. PubMed ID: 9353031
[TBL] [Abstract][Full Text] [Related]
3. Identification of iron-responsive proteins expressed by Chlamydia trachomatis reticulate bodies during intracellular growth.
Dill BD; Dessus-Babus S; Raulston JE
Microbiology (Reading); 2009 Jan; 155(Pt 1):210-219. PubMed ID: 19118361
[TBL] [Abstract][Full Text] [Related]
4. Ferritin heavy chain-mediated iron homoeostasis regulates expression of IL-10 in Chlamydia trachomatis-infected HeLa cells.
Vardhan H; Gupta R; Jha R; Bhengraj AR; Mittal A
Cell Biol Int; 2011 Aug; 35(8):793-8. PubMed ID: 21413929
[TBL] [Abstract][Full Text] [Related]
5. Quantitative monitoring of the Chlamydia trachomatis developmental cycle using GFP-expressing bacteria, microscopy and flow cytometry.
Vromman F; Laverrière M; Perrinet S; Dufour A; Subtil A
PLoS One; 2014; 9(6):e99197. PubMed ID: 24911516
[TBL] [Abstract][Full Text] [Related]
6. Low iron availability modulates the course of Chlamydia pneumoniae infection.
Al-Younes HM; Rudel T; Brinkmann V; Szczepek AJ; Meyer TF
Cell Microbiol; 2001 Jun; 3(6):427-37. PubMed ID: 11422085
[TBL] [Abstract][Full Text] [Related]
7. Colocalization of ferroportin-1 with hephaestin on the basolateral membrane of human intestinal absorptive cells.
Han O; Kim EY
J Cell Biochem; 2007 Jul; 101(4):1000-10. PubMed ID: 17486601
[TBL] [Abstract][Full Text] [Related]
8. Commonly prescribed β-lactam antibiotics induce C. trachomatis persistence/stress in culture at physiologically relevant concentrations.
Kintner J; Lajoie D; Hall J; Whittimore J; Schoborg RV
Front Cell Infect Microbiol; 2014; 4():44. PubMed ID: 24783061
[TBL] [Abstract][Full Text] [Related]
9. Effects of sustained antibiotic bactericidal treatment on Chlamydia trachomatis-infected epithelial-like cells (HeLa) and monocyte-like cells (THP-1 and U-937).
Mpiga P; Ravaoarinoro M
Int J Antimicrob Agents; 2006 Apr; 27(4):316-24. PubMed ID: 16527461
[TBL] [Abstract][Full Text] [Related]
10. Ferroportin-mediated mobilization of ferritin iron precedes ferritin degradation by the proteasome.
De Domenico I; Vaughn MB; Li L; Bagley D; Musci G; Ward DM; Kaplan J
EMBO J; 2006 Nov; 25(22):5396-404. PubMed ID: 17082767
[TBL] [Abstract][Full Text] [Related]
11. Wild-type and mutant ferroportins do not form oligomers in transfected cells.
Gonçalves AS; Muzeau F; Blaybel R; Hetet G; Driss F; Delaby C; Canonne-Hergaux F; Beaumont C
Biochem J; 2006 Jun; 396(2):265-75. PubMed ID: 16457665
[TBL] [Abstract][Full Text] [Related]
12. Treatment of Chlamydia trachomatis with a small molecule inhibitor of the Yersinia type III secretion system disrupts progression of the chlamydial developmental cycle.
Wolf K; Betts HJ; Chellas-Géry B; Hower S; Linton CN; Fields KA
Mol Microbiol; 2006 Sep; 61(6):1543-55. PubMed ID: 16968227
[TBL] [Abstract][Full Text] [Related]
13. Chlamydial Hsp60-2 is iron responsive in Chlamydia trachomatis serovar E-infected human endometrial epithelial cells in vitro.
LaRue RW; Dill BD; Giles DK; Whittimore JD; Raulston JE
Infect Immun; 2007 May; 75(5):2374-80. PubMed ID: 17307941
[TBL] [Abstract][Full Text] [Related]
14. Using Fluorescent Proteins to Visualize and Quantitate Chlamydia Vacuole Growth Dynamics in Living Cells.
Zuck M; Feng C; Hybiske K
J Vis Exp; 2015 Oct; (104):. PubMed ID: 26484535
[TBL] [Abstract][Full Text] [Related]
15. Persistently elevated level of IL-8 in Chlamydia trachomatis infected HeLa 229 cells is dependent on intracellular available iron.
Vardhan H; Dutta R; Vats V; Gupta R; Jha R; Jha HC; Srivastava P; Bhengraj AR; Singh Mittal A
Mediators Inflamm; 2009; 2009():417658. PubMed ID: 19503841
[TBL] [Abstract][Full Text] [Related]
16. Ferroportin diseases: functional studies, a link between genetic and clinical phenotype.
Détivaud L; Island ML; Jouanolle AM; Ropert M; Bardou-Jacquet E; Le Lan C; Mosser A; Leroyer P; Deugnier Y; David V; Brissot P; Loréal O
Hum Mutat; 2013 Nov; 34(11):1529-36. PubMed ID: 23943237
[TBL] [Abstract][Full Text] [Related]
17. Cell-specific regulation of Ferroportin transcription following experimentally-induced acute anemia in mice.
Chiabrando D; Fiorito V; Marro S; Silengo L; Altruda F; Tolosano E
Blood Cells Mol Dis; 2013 Jan; 50(1):25-30. PubMed ID: 22921471
[TBL] [Abstract][Full Text] [Related]
18. Estrogen contributes to regulating iron metabolism through governing ferroportin signaling via an estrogen response element.
Qian Y; Yin C; Chen Y; Zhang S; Jiang L; Wang F; Zhao M; Liu S
Cell Signal; 2015 May; 27(5):934-42. PubMed ID: 25660146
[TBL] [Abstract][Full Text] [Related]
19. Multifunctional analysis of Chlamydia-specific genes in a yeast expression system.
Sisko JL; Spaeth K; Kumar Y; Valdivia RH
Mol Microbiol; 2006 Apr; 60(1):51-66. PubMed ID: 16556220
[TBL] [Abstract][Full Text] [Related]
20. Ferroportin is a manganese-responsive protein that decreases manganese cytotoxicity and accumulation.
Yin Z; Jiang H; Lee ES; Ni M; Erikson KM; Milatovic D; Bowman AB; Aschner M
J Neurochem; 2010 Mar; 112(5):1190-8. PubMed ID: 20002294
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
